Saudi Pharmaceutical Industries and Medical Appliances Corporation

SASE:2070 주식 보고서

시가총액: ر.س3.9b

Saudi Pharmaceutical Industries and Medical Appliances 과거 수익 실적

과거 기준 확인 0/6

Saudi Pharmaceutical Industries and Medical Appliances은 연평균 27.8%의 비율로 수입이 증가해 온 반면, Pharmaceuticals 산업은 연평균 10.3%의 비율로 수입이 증가했습니다. 매출은 연평균 0.2%의 비율로 증가했습니다.

주요 정보

27.8%

수익 성장률

27.8%

EPS 성장률

Pharmaceuticals 산업 성장12.4%
매출 성장률0.2%
자기자본 수익률-0.2%
순이익-1.1%
최근 수익 업데이트30 Jun 2024

최근 과거 실적 업데이트

Recent updates

Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump

Sep 05
Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump

Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing

Mar 21
Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?

Jun 26
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?

Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?

Mar 14
Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?

Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price

Aug 02
Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60

May 19
Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60

One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates

May 12
One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates

A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Feb 20
A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit

Nov 18
Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit

Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?

Mar 30
Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?

Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?

Feb 23
Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?

What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition

Jan 19
What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?

Dec 16
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?

수익 및 비용 분석

Saudi Pharmaceutical Industries and Medical Appliances 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

SASE:2070 수익, 비용 및 수입 (SAR Millions )
날짜수익수익G+A 비용R&D 비용
30 Jun 241,562-1859048
31 Mar 241,597-4061346
31 Dec 231,653-2061641
30 Sep 231,686-7465547
30 Jun 231,662-7866051
31 Mar 231,564-14267347
31 Dec 221,422-15263143
30 Sep 221,425-9458951
30 Jun 221,379-4256341
31 Mar 221,3943854736
31 Dec 211,4603053729
30 Sep 211,4715752714
30 Jun 211,53211751920
31 Mar 211,53411051320
31 Dec 201,55513053220
30 Sep 201,521-1146111
30 Jun 201,491-1536111
31 Mar 201,518-3656577
31 Dec 191,487-43465313
30 Sep 191,743-16358640
30 Jun 191,626-20459440
31 Mar 191,566655139
31 Dec 181,5037454140
30 Sep 181,3136651734
30 Jun 181,3666150037
31 Mar 181,3758545939
31 Dec 171,38613948837
30 Sep 171,31527458936
30 Jun 171,29529660531
31 Mar 171,32928965431
31 Dec 161,25927763331
30 Sep 161,44812456348
30 Jun 161,49914954441
31 Mar 161,59534755933
31 Dec 151,70535756125
30 Sep 151,6044575740
30 Jun 151,5624655700
31 Mar 151,5003255580
31 Dec 141,4703175520
30 Sep 141,4242835470
30 Jun 141,3812795280
31 Mar 141,3512955160
31 Dec 131,3112675020

양질의 수익: 2070 은(는) 현재 수익성이 없습니다.

이익 마진 증가: 2070 은(는) 현재 수익성이 없습니다.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: 2070 은(는) 수익성이 없지만 지난 5년 동안 연간 27.8% 의 비율로 손실을 줄였습니다.

성장 가속화: 현재 수익성이 없기 때문에 2070 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: 2070 은(는) 수익성이 없어 지난 해 수익 성장을 Pharmaceuticals 업계( 7.1% )와 비교하기 어렵습니다.


자기자본 수익률

높은 ROE: 2070 현재 수익성이 없기 때문에 마이너스 자본 수익률( -0.18% )을 갖습니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기